Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: Implication in the regulation of intracellular calcium

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 1, 2007, Pages 43-53

  Jacques, Danielle ^a   Abdel Samad, Dima ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

BIBP 3226; Cardiomyocytes; Confocal microscopy; Endocardial endothelium; Intracellular calcium; Neuropeptide Y; Vascular smooth muscle; Y1 receptors

Indexed keywords

CALCIUM; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; ANILINE DERIVATIVE; FLUO 3; FLUORESCENT DYE; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR; UNCLASSIFIED DRUG; XANTHENE DERIVATIVE;

CARDIOVASCULAR SYSTEM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SHORT SURVEY; AORTA; CALCIUM SIGNALING; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; CYTOPLASM; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENDOCARDIUM; HEART CONTRACTION; METABOLISM; METHODOLOGY; REVIEW; SMOOTH MUSCLE FIBER; TIME; VASCULAR SMOOTH MUSCLE;

ANILINE COMPOUNDS; AORTA; CALCIUM; CALCIUM SIGNALING; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCARDIUM; ENDOTHELIAL CELLS; FLUORESCENT DYES; HUMANS; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; TIME FACTORS; XANTHENES;

EID: 34250835936     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-106     Document Type: Short Survey

References (78)

1. Abdel-Samad, D., Jacques, D., Perreault, C., and Provost, C. 2007. NPY regulates human endocardial endothelial cell function. Peptides, In press.
2. Abounader, R., Elhusseiny, A., Cohen, Z., Olivier, A., Stanimirovic, D., Quirion, R., and Hamel, E. 1999. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture. J. Cereb. Blood Flow Metab. 19: 155-163.
3. Allen, J.M., Bircham, P.M., Edwards, A.V., Tatemoto, K., and Bloom, S.R. 1983. Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul. Pept. 6: 247-253. doi:10.1016/0167-0115(83)90143-X.
4. Balasubramaniam, A. 2002. Clinical potentials of neuropeptide Y family of hormones. Am. J. Surg. 183: 430-434. doi:10.1016/S0002-9610(02)00803-6.
5. Balasubramaniam, A., Grupp, I., Matlib, M.A., Benza, R., Jackson, R.L., Fischer, J.E., and Grupp, G. 1988. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hearts; effects of NPY on atrial and ventricular strips of rat heart and on rabbit heart mitochondria. Regul. Pept. 21: 289-299. doi:10.1016/0167-0115(88)90012-2.
6. Bard, J.A., Walker, M.W., Branchek, T.A., and Weinshank, R.L. 1995. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270: 26762-26765.
7. Bkaily, G. 1992. Single heart cells as model for studying cardiac toxicology. In In vitro methods in toxicology. Edited by G. Jolles and A. Cordier. Academic Press, London. pp. 289-334.
8. 2+ channel by PN 200-110 in heart and vascular smooth muscle. Mol. Cell. Biochem. 117: 93-106.
9. Bkaily, G., Pothier, P., D'Orleans-Juste, P., Simaan, M., Jacques, D., Jaalouk, D., et al. 1997a. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol. Cell. Biochem. 172: 171-194. doi:10.1023/A:1006840228104.
10. 2+ in aortic vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 75: 652-660. doi:10.1139/cjpp-75-6-652.
11. Bkaily, G., D'Orléans-Juste, P., Pothier, P., Calixto, J.B., and Yunes, R. 1997c. Nuclear membrane receptors and channels: potential therapeutical targets for drug action. Drug Dev. Res. 42: 211-222. doi:10.1002/(SICI)1098-2299(199711/12)42:3/4〈211::AID-DDR12〉3.0. CO;2-B.
12. Bkaily, G., Jacques, D., Hassan, G., Choufani, S., and D'Orléans-Juste, P. 2001. Using confocal imaging to measure changes in intracellular ions. In Receptors: structure and function. Edited by C. Stanford and R. Horton. Oxford University Press, Oxford. pp. 209-231.
13. Bkaily, G., Jacques, D., D'Orléans-Juste, P., Gobeil, F., Jr., Chemtob, S., Choufani, S., and Nader, M. 2003. Nuclear membranes channels, exchangers and G-protein coupled receptors: a new target for drug action. Curr. Topics Pharmacol. 7: 269-278.
14. + exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells. Can. J. Physiol. Pharmacol. 84: 431-441. doi:10.1139/Y06-002.
15. Bristow, M.R., Krause-Steinrauf, H., Nuzzo, R., Liang, C.S., Lindenfeld, J., Lowes, B.D., et al. 2004. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation, 110: 1437-1442. doi:10.1161/01.CIR.0000141297.50027.A4.
16. Brutsaert, D.L. 2003. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev. 83: 59-115.
17. Brutsaert, D.L., and Andries, L.J. 1992. The endocardial endothelium. Am. J. Physiol. 263: H985-H1002.
18. Brutsaert, D.L., De Keulenaer, G.W., Fransen, P., Mohan, P., Kaluza, G.L., Andries, L.J., Rouleau, J.L., and Sys, S.U. 1996. The cardiac endothelium: functional morphology, development, and physiology. Prog. Cardiovasc. Dis. 39: 239-262.
19. Brutsaert, D.L., Fransen, P., Andries, L.J., De Keulenaer, G.W., and Sys, S.U. 1998. Cardiac endothelium and myocardial function. Cardiovasc. Res. 38: 281-290. doi:10.1016/S0008-6363(98)00044-3.
20. Cines, D.B., Pollak, E.S., Buck, C.A., Loscalzo, J., Zimmerman, G.A., McEver, R.P., et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 91: 3527-3561.
21. Clarke, J.G., Davies, G.J., Kerwin, R., Hackett, D., Larkin, S., Dawbarn, D., et al. 1987. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet, 1: 1057-1059.
22. Crick, S.J., Sheppard, M.N., Anderson, R.H., Polak, J.M., and Wharton, J. 1996. A quantitative assessment of innervation in the conduction system of the calf heart. Anat. Rec. 245: 685-698. doi:10.1002/(SICI)1097-0185(199608) 245:4〈685::AID-AR9〉3.0.CO;2-N.
23. Crick, S.J., Sheppard, M.N., Ho, S.Y., and Anderson, R.H. 1999a. Localization and quantitation of autonomic innervation in the porcine heart I: conduction system. J. Anat. 195: 341-357. doi:10.1046/j.1469-7580.1999. 19530341.x.
24. Crick, S.J., Anderson, R.H., Ho, S.Y., and Sheppard, M.N. 1999b. Localization and quantitation of autonomic innervation in the porcine heart II: endocardium, myocardium and epicardium. J. Anat. 195: 359-373. doi:10.1046/j.1469-7580.1999.19530359.x.
25. 1 receptor antagonist: a review of its pharmacological properties. Regul. Pept. 65: 71-77. doi:10.1016/0167-0115(96)00074-2.
26. Dumont, Y., Mattel, J.C., Fournier, A., St-Pierre, S., and Quirion, R. 1992. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol. 38: 125-167. doi:10.1016/0301- 0082(92)90038-G.
27. Ekblad, E., Edvinsson, L., Wahlestedt, C., Uddman, R., Hakanson, R., and Sundler, F. 1984. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul. Pept. 8: 225-235. doi:10.1016/0167- 0115(84)90064-8.
28. Eva, C., Keinanen, K., Monyer, H., Seeburg, P., and Sprengel, R. 1990. Molecular Cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett. 271: 81-84. doi:10.1016/0014- 5793(90)80377-U.
29. Feuerstein, G.Z., and Lee, E.W. 2006. Neuropeptide Y and the heart: implication for myocardial infarction and heart failure. In NPY family of peptides in neurobiology, cardiovascular and metabolic disorders: from genes to therapeutics. Edited by Z. Zukowska and G.Z. Feuerstein. Birkhäuser Verlag, Basel. pp. 113-122.
30. Franco-Cereceda, A., Lundberg, J.M., and Dahlof, C. 1985. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiol. Scand. 124: 361-369.
31. 1 receptors in vascular pharmacology. Eur. J. Pharmacol. 349: 1-14. doi:10.1016/S0014-2999(98)00242-8.
32. 2 receptor subtype. J. Biol. Chem. 270: 26758-26761.
33. Gerald, C., Walker, M.W., Criscione, L., Gustafson, E.L., Batzl-Hartmann, C., Smith, K.E., et al. 1996. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (London), 382: 168-171. doi:10.1038/382168a0.
34. Ghersi, G., Chen, W., Lee, E.W., and Zukowska, Z. 2001. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides, 22: 453-458. doi:10.1016/S0196-9781(01) 00340-0.
35. Goldberg, Y., Taimor, G., Piper, H.M., and Schluter, K.D. 1998. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y. Am. J. Physiol. 275: C1207-C1215.
36. Grundemar, L., Jonas, S.E., Morner, N., Hogestatt, E.D., Wahlestedt, C., and Hakanson, R. 1992. Characterization of vascular neuropeptide Y receptors. Br. J. Pharmacol. 105: 45-50.
37. Gu, J., Polak, J.M., Allen, J.M., Huang, W.M., Sheppard, M.N., Tatemoto, K., and Bloom, S.R. 1984. High concentrations of a novel peptide, neuropeptide Y, in the innervation of mouse and rat heart. J. Histochem. Cytochem. 32: 467-472.
38. Herzog, H., Hon, Y.J., Ball, H.J., Hayes, G., Shine, J., and Selbie, L.A. 1992. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. U.S.A. 89: 5794-5798. doi:10.1073/pnas.89.13.5794.
39. Hulting, J., Sollevi, A., Ullman, B., Franco-Cereceda, A., and Lundberg, J.M. 1990. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovasc. Res. 24: 102-108.
40. 2+ in heart and vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 78: 162-172. doi:10.1139/cjpp-78-2-162.
41. 2+ in human endocardial endothelium. J. Cardiovasc. Pharmacol. 36: S397-S400.
42. 1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. Can. J. Physiol. Pharmacol. 81: 288-300. doi:10.1139/y02-165.
43. Jacques, D., Abdel Malak, N.A., Sader, S., and Perreault, C. 2003b. Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium. Can. J. Physiol. Pharmacol. 81: 259-266. doi:10.1139/y03-046.
44. Jacques, D., Descorbeth, M., Abdel-Samad, D., Provost, C., Perreault, C., and Jules, F. 2005. The distribution and density of ET-1 and its receptors are different in human right and left ventricular endocardial endothelial cells. Peptides, 26: 1427-1435. doi:10.1016/j.peptides.2005.03.048.
45. Jacques, D., Sader, S., Perreault, C., and Abdel-Samad, D. 2006a. NPY and NPY receptors: presence, distribution and roles in the regulation of the endocardial endothelium and cardiac function. In NPY family of peptides in neurobiology, cardiovascular and metabolic disorders: from genes to therapeutics. Edited by Z. Zukowska and G.Z. Feuerstein. Birkhäuser Verlag, Basel, pp. 77-87.
46. Jacques, D., Sader, S., Perreault, C., Abdel-Samad, D., Jules, F., and Provost, C. 2006b. NPY, ET-1, and Ang II nuclear receptors in human endocardial endothelial cells. Can. J. Physiol. Pharmacol. 84: 299-307. doi.10.1139/Y05-158.
47. Kuruvilla, L., and Kartha, C.C. 2003. Molecular mechanisms in endothelial regulation of cardiac function. Mol. Cell. Biochem. 253: 113-123. doi:10.1023/A:1026061507004.
48. 1 type. J. Biol. Chem. 267: 10935-10938.
49. Lee, E.W., Michalkiewicz, M., Kitlinska, J., Kalevic, I., Switalska, H., Yoo, P., et al. 2003. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J. Clin. Invest. 111: 1853-1862. doi:10.1172/JCI200316929.
50. Li, L., Lee, E.W., Ji, H., and Zukowska, Z. 2003. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 23: 1204-1210.
51. 1 receptor antagonist BIBP 3226. Br. J. Pharmacol. 116: 2971-2982.
52. Lundberg, J.M., Hua, X.Y., and Franco-Cereceda, A. 1984. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol. Scand. 121: 325-332.
53. Lundberg, J.M., Franco-Cereceda, A., Lacroix, J.S., and Pernow, J. 1991. Release of vasoactive peptides from autonomic and sensory nerves. Blood Vessels, 28: 27-34.
54. Lundell, I., Blomqvist, A.G., Berglund, M.M., Schober, D.A., Johnson, D., Statnick, M.A., et al. 1995. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. 270: 29123-29128.
55. Marron, K., Wharton, J., Sheppard, M.N., Gulbenkian, S., Royston, D., Yacoub, M.H., Anderson, R.H., and Polak, J.M. 1994. Human endocardial innervation and its relationship to the endothelium: an immunohistochemical, histochemical, and quantitative study. Cardiovasc. Res. 28: 1490-1499.
56. Marron, K., Wharton, J., Sheppard, M.N., Fagan, D., Royston, D., Kuhn, D.M., et al. 1995. Distribution, morphology, and neurochemistry of endocardial and epicardial nerve terminal arborizations in the human heart. Circulation, 92: 2343-2351.
57. Marron, K., Yacoub, M.H., Polak, J.M., Sheppard, M.N., Fagan, D., Whitehead, B.F., et al. 1996. Innervation of human atrioventricular and arterial valves. Circulation, 94: 368-375.
58. Maturi, M.F., Greene, R., Speir, E., Burrus, C., Dorsey, L.M., Markle, D.R., et al. 1989. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs. J. Clin. Invest. 83: 1217-1224.
59. 2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur. J. Pharmacol. 336: 257-265. doi:10.1016/S0014-2999(97)01258-2.
60. Mebazaa, A., Mayoux, E., Maeda, K., Martin, L.D., Lakatta, E.G., Robotham, J.L., and Shah, A.M. 1993. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am. J. Physiol. 265: H1841-H1846.
61. Michel, M.C., Wirth, S.C., Zerkowski, H.R., Maisel, A.S., and Motulsky, H.J. 1989. Lack of inotropic effects of neuropeptide Y in human myocardium. J. Cardiovasc. Pharmacol. 14: 919-922.
62. 2+. Biochem. Int. 22: 205-212.
63. Millar, B.C., Weis, T., Piper, H.M., Weber, M., Borchard, U., McDermott, B.J., and Balasubramaniam, A. 1991. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am. J. Physiol. 261: H1727-H1733.
64. Millar, B.C., Schluter, K.D., Zhou, X.J., McDermott, B.J., and Piper, H.M. 1994. Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. Am. J. Physiol. 266: C1271-C1277.
65. Nicholl, S.M., Bell, D., Spiers, J., and McDermott, B.J. 2002. Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes. Eur. J. Pharmacol. 441: 23-34. doi:10.1016/S0014-2999(02)01440-1.
66. Onuoha, G.N., Nicholls, D.P., Alpar, E.K., Ritchie, A., Shaw, C., and Buchanan, K. 1999. Regulatory peptides in the heart and major vessels of man and mammals. Neuropeptides, 33: 165-172. doi:10.1054/npep.1999.0017.
67. Pons, J., Kitlinska, J., Ji, H., Lee, E.W., and Zukowska, Z. 2003. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can. J. Physiol. Pharmacol. 81: 177-185. doi:10.1139/y02-166.
68. i proteins by neuropeptide Y (NPY) in the rat left ventricle. Biochem. Pharmacol. 63: 2063-2068. doi:10.1016/S0006-2952(02)00986-3.
69. 2+-triggered exocytosis. Science (Washington, D.C.), 298: 781-785. doi:10.1126/science.1075375.
70. Shah, A.M., Grocott-Mason, R.M., Pepper, C.B., Mebazaa, A., Henderson, A.H., Lewis, M.J., and Paulus, W.J. 1996. The cardiac endothelium: cardioactive mediators. Prog. Cardiovasc. Dis. 39: 263-284.
71. Shigeri, Y., Mihara, S., and Fujimoto, M. 1991. Neuropeptide Y receptor in vascular smooth muscle. J. Neurochem. 56: 852-859. doi:10.1111/j.1471-4159.1991.tb02001.x.
72. Tatemoto, K., Carlquist, M., and Mutt, V. 1982. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (London), 296: 659-660. doi:10.1038/296659a0.
73. Weinberg, D.H., Sirinathsinghji, D.J., Tan, C.P., Shiao, L.L., Morin, N., Rigby, M.R., et al. 1996. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 271: 16435-16438.
74. Westfall, T.C., Han, S.P., Knuepfer, M., Martin, J., Chen, X.L., del Valle, K., Ciarleglio, A., and Naes, L. 1990. Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide. Br. J. Clin. Pharmacol. 30: 75S-82S.
75. Yamada, H., Fabris, B., Allen, A.M., Jackson, B., Johnston, C.I., and Mendelsohn, A.O. 1991. Localization of angiotensin converting enzyme in rat heart. Circ. Res. 68: 141-149.
76. Zukowska-Grojec, Z., Marks, E.S., and Haass, M. 1987. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Am. J. Physiol. 253: H1234-H1239.
77. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., et al. 1998a. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83: 187-195.
78. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Fisher, T.A., and Ji, H. 1998b. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul. Pept. 75-76: 231-238. doi:10.1016/S0167-0115(98)00073-1.